AI-based drug developer Basecamp valued at $800 million after $140 million funding round

AI-based drug developer Basecamp valued at $800 million after $140 million funding round. It centres on NVIDIA, and also names Anthropic. Reported by The Economic Times. Bharat Hunt files it under AI Funding and AI Coding — the section covering rounds, valuations, acquisitions and investor moves in AI.

Written by Bharat Hunt from the headline and the coverage below. The original reporting is the source of truth.